1. Role: Associate Dean. Scope: College. Description: Lead research enterprise of the College of Pharmacy. Represent the College at the HSC level. Mentor researchers. Date: 2020.
Vibhudutta Awasthi, Ph.D.
Professor and Associate Dean for Research
Pharmaceutical Sciences
Phone (405) 271-6593 x47331
Fax (405) -271-7505
Office CPB 309
Summary
My research interests are in the development of radiopharmaceuticals, small animal imaging and use of radiological imaging techniques to answer physiological questions. My current research focuses on the development of liposome encapsulated hemoglobin as an artificial oxygen carrier and he is studying cerebral oxygen metabolism using positron emission tomography. I am a board certified nuclear pharmacist with expertise in areas related to drug delivery, formulation development, nuclear pharmacy and small animal nuclear imaging.
Publications & Presentations
- 56. Pathuri G, Hedrick A F, January S E, Galbraith W, Awasthi V, Arnold C D, Cowley B D, Galia H. Synthesis and in vivo evaluation of gallium-68-labeled glycine and hippurate conjugates for positron emission tomography renography. Journal of Labelled Compounds and Radiopharmaceuticals. 2015; 58 : 14-19
57. Yadav V, Nag O, Awasthi V. Biological evaluation of a new composition of liposome-encapsulated hemoglobin (LEH). Artif Organs. 2014; 38 : 625-633
58. Pathuri G, Madka V, Hedrick A F, Lightfoot S A, Awasthi V, Cowley, Jr B D, Rao C V, Gali H. Evaluation of 99mTc-probestin SPECT as a novel technique for noninvasive imaging of kidney aminopeptidase N expression. Mol Pharm. 2014; 11 : 2948-2953
59. Awwad H O, Simpson-Durand C D, Gonzalez L P, Tompkins P, Zhang Y, Lerner M, Brackett D J, Sherry D M, Awasthi V, Standifer K. Post-blast treatment with Nociceptin/Orphanin FQ peptide receptor antagonist reduces traumatic brain injury-induced cerebral hypoxia. Neuroscience 2014 program and website. 2014
60. Yadav V R, Hussain A, Kaustuv S, Awasthi V. Remediation of hemorrhagic shock-induced intestinal barrier dysfunction by treatment with diphenyldihaloketones EF24 and CLEFMA. J Pharmacol Exp Ther. 2014; 351 : 413-422
Grants
- 6. STTR Phase I: Cardiotropic Atorvastatin Liposomes for Myocardial Reperfusion Injury. NSF. Start Date: 2023. End Date: 2021.
7. Pharmacotherapy of Traumatic Brain Injury Accompanied by Hemorrhagic Shock. NIH. Start Date: 2017. End Date: 2022.
8. Development of Bioactive Peptides for the Inhibition of Neuroinflammation and Neurotoxicity Induced by Amyloid-beta. Non-federal. Start Date: 2020. End Date: 2021.
9. Immunokinetics of superhydrophilic polymer-modified liposome encapsulated hemoglobin. Non-federal. Start Date: 2017. End Date: 2020.
10. PET Imaging Agent For Myocardial Infarction. NIH. Start Date: 2019. End Date: 2019.
Awards and Honors
- 6. Sandra K and David L Gilliland Chair in Nuclear Pharmacy . Date: 2012.
7. Indo-American Society of Nuclear Medicine. President. Date: 2010.
Education
- 1. Degree: Ph D. Sanjay Gandhi Postgraduate Institute of Medical Sciences . Date: 1994.
2. Degree: M. Pharm.. Dr. Hari Singh Gour Vishwavidyalaya, Sagar (Formerly, University of Sagar). Date: 1990.
3. Degree: B. Pharm. Dr. Hari Singh Gour Vishwavidyalaya, Sagar (Formerly, University of Sagar). Date: 1988.
Administrative Assignments
2. Role: Director. Scope: University. Description: Direction and conduct of nuclear imaging services for biomedical investigators; Production of PET radiotracers for preclinical imaging and preparation for regulatory compliance for clinical applications; Consultations with researchers about imaging and tracer applications. Date: 2007.
External Connections and Partnerships
no results